SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's Laboratories shines despite reporting 30% fall in Q2 consolidated net profit

29 Oct 2020 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 5009.90, up by 60.10 points or 1.21% from its previous closing of Rs. 4949.80 on the BSE.

The scrip opened at Rs. 4935.00 and has touched a high and low of Rs. 5041.60 and Rs. 4892.80 respectively. So far 28444 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5514.65 on 21-Sep-2020 and a 52 week low of Rs. 2497.60 on 19-Mar-2020.

Last one week high and low of the scrip stood at Rs. 5148.00 and Rs. 4832.40 respectively. The current market cap of the company is Rs. 83066.84 crore.

The promoters holding in the company stood at 26.74%, while Institutions and Non-Institutions held 43.50% and 15.6% respectively.

Dr. Reddy's Laboratories has reported 64.76% fall in its net profit of Rs 481.00 crore for the quarter ended September 30, 2020 as against net profit of Rs 1365.10 crore for the same quarter in the previous year. Total income of the company decreased 4.27% at Rs 3,372.40 crore for Q2FY21 as compared Rs 3,522.70 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 30.27% fall in its net profit of associate at Rs 771.80 crore for the quarter ended September 30, 2020 as against net profit of Rs 1106.80 crore for the same quarter in the previous year. However, total income of the company increased by 1.96% at Rs 4,962.10 crore for Q2FY21 as compared Rs 4,866.80 crore for the corresponding quarter previous year.

Dr. Reddys Labs. Share Price

1356.85 -19.45 (-1.41%)
30-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.70
Dr. Reddys Labs. 1356.85
Cipla 1465.15
Zydus Lifesciences 1112.20
Lupin 2420.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: